Clinical trial

A Study of Cadonilimab Combined With Regorafenib in Patients With Advanced HCC

NCT05773105

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-09-19

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2023-09-19Date precision: day

Registry last updated2026-06-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Advanced Hepatocellular Carcinomaunresolved

Interventions

Cadonilimab+regorafenibDRUG

Sponsors & collaborators

Sun Yat-sen Universitylead sponsor

Mapped research locations

GuangzhouGuangdong, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05773105 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.